| EMA number | EMEA/H/C/000757 |
| ATC code | D06AX13 |
| Authorisation | 24 May 2007 |
| Withdrawn | 25 February 2019 |
| Revision | 15 |
Short term treatment of the following superficial skin infections: impetigo; infected small lacerations, abrasions or sutured wounds. See sections 4.4 and 5.1 for important information regarding the clinical activity of retapamulin against different types of Staphylococcus aureus. Consideration should be given to official guidance on the appropriate use of antibacterial agents.